Wave Life Sciences (WVE) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $196.2 million.
- Wave Life Sciences' Cash & Equivalents fell 3689.68% to $196.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.2 million, marking a year-over-year decrease of 3689.68%. This contributed to the annual value of $302.1 million for FY2024, which is 5077.44% up from last year.
- Per Wave Life Sciences' latest filing, its Cash & Equivalents stood at $196.2 million for Q3 2025, which was down 3689.68% from $208.5 million recorded in Q2 2025.
- Wave Life Sciences' 5-year Cash & Equivalents high stood at $310.9 million for Q3 2024, and its period low was $88.5 million during Q4 2022.
- Its 5-year average for Cash & Equivalents is $176.5 million, with a median of $154.0 million in 2024.
- In the last 5 years, Wave Life Sciences' Cash & Equivalents tumbled by 4273.51% in 2021 and then soared by 12639.3% in 2023.
- Quarter analysis of 5 years shows Wave Life Sciences' Cash & Equivalents stood at $150.6 million in 2021, then tumbled by 41.22% to $88.5 million in 2022, then surged by 126.39% to $200.4 million in 2023, then soared by 50.77% to $302.1 million in 2024, then tumbled by 35.04% to $196.2 million in 2025.
- Its last three reported values are $196.2 million in Q3 2025, $208.5 million for Q2 2025, and $243.1 million during Q1 2025.